Methods for Isolation and Reprogramming of Various Somatic Cell Sources into iPSCs
Shunit Neeman-Egozi1, Polina Baskin1, Ofer Binah2
1Department of Physiology, Biophysics and Systems Biology, Rappaport Faculty of Medicine and Research Institute, Technion, Haifa, Israel.
Methods in Molecular Biology (Clifton, N.J.)
|June 15, 2021
Summary
Induced pluripotent stem cells (iPSCs) are reprogrammed adult cells with embryonic stem cell properties. This breakthrough enables applications in regenerative medicine and disease modeling for personalized treatments.
Area of Science:
- Stem Cell Biology
- Reproductive Biology
- Genetics
Background:
- Induced pluripotent stem cells (iPSCs) are derived from adult somatic cells.
- Reprogramming involves ectopic expression of key transcription factors like OCT3/4, SOX2, c-Myc, and KLF4.
- iPSCs share characteristics with embryonic stem cells, including self-renewal and differentiation potential.
Purpose of the Study:
- To summarize the generation and characteristics of iPSCs.
- To highlight the significance of iPSC technology in various research fields.
- To underscore the potential of iPSCs for personalized medicine.
Main Methods:
- Ectopic expression of OCT3/4, SOX2, c-Myc, and KLF4 in somatic cells.
- In vitro expansion and differentiation assays.
- Characterization of iPSC pluripotency and germ layer differentiation.
Main Results:
- Successful reprogramming of somatic cells into iPSCs.
- Demonstration of iPSC pluripotency and differentiation into endoderm, mesoderm, and ectoderm.
- Establishment of iPSCs as a versatile tool in research.
Conclusions:
- iPSC technology represents a significant advancement in stem cell biology.
- iPSCs offer a powerful platform for regenerative medicine, developmental studies, and disease modeling.
- The potential for patient-specific iPSC generation paves the way for personalized medicine.
More Related Videos
Related Concept Videos
Somatic to iPS Cell Reprogramming
2.4K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.4K
Induced Pluripotent Stem Cells
4.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.7K
Induced Pluripotent Stem Cells
24.8K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.8K
Methods of Nuclear Reprogramming
1.9K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.9K
iPS Cell Differentiation
2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
EPS and iPS Cells in Disease Research
3.1K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K


